Hello Seanl
"Imagine the outrage from these companies if we announce the cure for Hep C and Aids, one shot cure...."
Plus Hep B which is a much bigger market and for which there is currently no cure. I think that were BLT to develop definite leads to cure Hep B then this would certainly accelerate Gilead's interest particularly if it were used in combination with a nucleoside antagonist.
In the meantime it will be interesting to see if Gilead bid for Arrowhead.
PDYOR.
- Forums
- ASX - By Stock
- gileads sovaldi from sa
Hello Seanl"Imagine the outrage from these companies if we...
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online